Management of polycystic ovary syndrome

Nurse Practitioner

Volumn 22, Issue 12, 1997, Pages 34-44

  Marantides, Deborah ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ESTROGEN;

FEMALE; HUMAN; METHODOLOGY; NURSE PRACTITIONER; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PATHOPHYSIOLOGY; PREGNANCY; REVIEW;

ANDROGEN ANTAGONISTS; ESTROGENS; FEMALE; HUMANS; NURSE PRACTITIONERS; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY;

EID: 0031302054     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/00006205-199712000-00004     Document Type: Article

References (20)

1. Franklin R, Brockman D: In Pursuit of Fertility. New York: Henry Holt, 1990.
2. Mura la T: Abnormal genital bleeding and secondary amenorrhea: common gynecological problems. J Obstet Gynecolol Neonat Nurs 1990; 19(l):26-36.
3. Franks S: Polycystic ovary syndrome. N Engl J Med 1995;333(13):853-58.
4. Speroff R, Glass RI-I, Kase NG: Clinical and Gynecological Endocrinology and Infertility. Philadelphia: Wilkens & Wilkens, 1994.
5. Gonzalez F, Chang L, Horab T, et al: Evidence for heterogenous etiologies of adrenal dysfunction in polycystic ovary syndrome. Fertil-Steril 1996; 66(3):354-60.
6. Stcvcns-Simon C: Clinical applications of adolescent sexual development. Nurs Pract 1993;168:18-29.
7. Loriaux D, Wild R: Contraceptive choices for women with endocrine complications. AmJ Obstet Gynecol 1993; 168(6):2021-26.
8. Wortsman J, Singh K, Murphy J: Evidence for the hypothalamic origin of the polycystic ovary syndrome. J Am College Obstet Gynecol 1981; 58(2): 137-41.
9. Givens J, Goodman R: Hirsutism and polycystic ovary syndrome. Hosp Prae 1986;21 (10):81-94.
10. Kyei-Mensah A, Zaidi J, Campbell S: Ultrasound diagnosis of polycystic ovary syndrome. Bailliere’s Clin Endocrinol Metab 1996;10(2):249-61.
11. Conway GS: Polycystic ovary syndrome: clinical aspects. Bailliere’s Clin Endocrinol Metab 1996;10(2):203-17.
12. Paolctti AM, Cagnacci A, Depau GF, et al: The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. Fertil-Steril 1996;66(4):527-32.
13. Lin-Tan S, Farhi J, Homberg R, et al: Induction of ovulation in clomiphene resistant polycystic ovary syndrome with pulsatile Gn-RH. Obstet Gynecol 1996;54(1):117-24.
14. Donesky BW, Adashi EY: Surgical ovulation induction: the role of ovarian diathermy in polycystic ovary syndrome. Bailliere’s Clin Endocrinol Metab 1996;10(2):293-95.
15. Coulam CB, Annegers JF, Kranz JS: Chronic syndromes and associated neoplasia. Obstet-Gynecol 1983;61 (2):403-07.
16. Schildkraut JM, Schwingl PJ, Bastos E, et al: Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996; 88(4):554-59.
17. McKeigue P: Cardiovascular disease and diabetes in women with polycystic ovary syndrome, Bailliere’s Clin Endocrinol Metab 1996;10(2):311-27.
18. Holte J: Disturbances in insulin secretion and sensitivity in women with polycystic ovary syndrome. Bailliere’s Clin Endocrinol Metab 1996;10(2):221-41.
19. Guzick DS, Talbot EO, Sutton-Tyrrell K, et al: Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case control study. AmJ Obstet Genecol 1996; 174(4): 1224-29.
20. Conway GS, Agrawal R, Betteridge DJ, et al: Risk factors for coronary artery disease in lean and obese women with polycystic ovary syndrome. Clin Endocrin 1992;37:119-25.